APBI 2016

Interaction between local & systemic treatment

Stage

Benefit HT DFS (%) 4.9-9.5 5.7-8.2 7.8-11.1 9.6-13.9 8.1-11.6 10.8-15.7 12.7-18.7

Benefit HT

OS (%)

(all 65y;N0;ER+;Her-)

T1a-bG1-3

0.3-1.4

T1cG1 T1cG2 T1cG3

0.9 2.0 3.3 2.4 4.3 5.9

G1 G2 G3

T2 <3cm T2 <3cm T2 <3cm